Recent advances in targeting malaria with nanotechnology-based drug carriers

References

• Abazari M, Ghaffari A, Rashidzadeh H, Momeni Badeleh S, Maleki Y. 2020. Current status and future outlook of nano‐based systems for burn wound management. J Biomed Mater Res B Appl Biomater. 108:1934–1952.
   PubMed Web of Science ®Google Scholar
• Abossie A, Yohanes T, Nedu A, Tafesse W, Damitie M. 2020. Prevalence of malaria and associated risk factors among febrile children under five years: a cross-sectional study in Arba Minch Zuria district. IDR. 13:363–372.
   Google Scholar
• Aderibigbe B, Mhlwatika Z, Nwamadi M, Balogun MO, Matshe WM. 2019. Synthesis, characterization and in vitro analysis of polymer-based conjugates containing dihydrofolate reductase inhibitors. J Drug Deliv Sci Technol. 50:388–401.
   Web of Science ®Google Scholar
• Aderibigbe BA. 2017a. Design of drug delivery systems containing artemisinin and its derivatives. Molecules. 22(2):323.
   Web of Science ®Google Scholar
• Aderibigbe BA. 2017b. Polymeric therapeutic delivery systems for the treatment of infectious diseases. Ther Deliv. 8(7):557–576.
   PubMed Web of Science ®Google Scholar
• Aderibigbe BA, Mhlwatika Z. 2016. Dual release kinetics of antimalarials from soy protein isolate‐carbopol‐polyacrylamide based hydrogels. J Appl Polym Sci. 133(37):43918–43925.
   Web of Science ®Google Scholar
• Aghajanzadeh M, Zamani M, Rashidzadeh H, Rostamizadeh K, Sharafi A, Danafar H. 2018. Amphiphilic Y shaped miktoarm star copolymer for anticancer hydrophobic and hydrophilic drugs codelivery: synthesis, characterization, in vitro, and in vivo biocompatibility study. J Biomed Mater Res. 106(11):2817–2826.
   Web of Science ®Google Scholar
• Aguiar L, Biosca A, Lantero E, Gut J, Vale N, Rosenthal PJ, Nogueira F, Andreu D, Fernàndez-Busquets X, Gomes P. 2019. Coupling the antimalarial cell penetrating peptide TP10 to classical antimalarial drugs primaquine and chloroquine produces strongly hemolytic conjugates. Molecules. 24(24):4559.
   Web of Science ®Google Scholar
• Aibani N, Khan TN, Callan B. 2020. Liposome mimicking polymersomes: a comparative study of the merits of polymersomes in terms of formulation and stability. Int J Pharm X. 2:100040.
   PubMedGoogle Scholar
• Alavi M, Karimi N, Safaei M. 2017. Application of various types of liposomes in drug delivery systems. Adv Pharm Bull. 7(1):3–9.
   PubMed Web of Science ®Google Scholar
• AlKadi HO. 2007. Antimalarial drug toxicity: a review. Chemotherapy. 53(6):385–391.
   PubMed Web of Science ®Google Scholar
• Alven S, Aderibigbe B. 2019. Combination therapy strategies for the treatment of malaria. Molecules. 24(19):3601.
   PubMed Web of Science ®Google Scholar
• Alven S, Aderibigbe B, Balogun MO, Matshe W, Ray SS. 2019. Polymer-drug conjugates containing antimalarial drugs and antibiotics. J Drug Deliv Sci Technol. 53:101171.
   Web of Science ®Google Scholar
• Aminake MN, Pradel G. 2013. Antimalarial drugs resistance in Plasmodium falciparum and the current strategies to overcome them. MMicrob Pathog Strateg Combat Format. 2013(1):1–774.
   Google Scholar
• Angira C, Otieno O, Muga R, Abong’o B. 2010. Factors contributing to antimalarial drug resistance in Rachuonyo district. Kenya East Afr J Public Health. 7(1):11–15.
   PubMedGoogle Scholar
• Asua V, Tukwasibwe S, Conrad M, Walakira A, Nankabirwa JI, Mugenyi L, Kamya MR, Nsobya SL, Rosenthal PJ. 2017. Plasmodium species infecting children presenting with malaria in Uganda. Am J Trop Med Hyg. 97(3):753–757.
   PubMed Web of Science ®Google Scholar
• Badhe PR. 2019. B antimalarial drug toxicity: a review. J Drug Deliv Ther. 9(4):720–725.
   Google Scholar
• Bagheri AR, Golenser J, Greiner A. 2020. Controlled and manageable release of antimalarial Artemisone by encapsulation in biodegradable carriers. Eur Polym J. 129:109625.
   Web of Science ®Google Scholar
• Bartoloni A, Zammarchi L. 2012. Clinical aspects of uncomplicated and severe malaria. Mediterr J Hematol Infect Dis. 4(1):e2012026.
   PubMedGoogle Scholar
• Baruah UK, Gowthamarajan K, Vanka R, Karri VVSR, Selvaraj K, Jojo GM. 2017. Malaria treatment using novel nano-based drug delivery systems. J Drug Target. 25(7):567–581.
   PubMed Web of Science ®Google Scholar
• Bashir A, Mustafa ZA, Abdelhameid I, Ibrahem R. 2017. Detection of malaria parasites using digital image processing. International Conference on Communication, Control, Computing and Electronics Engineering (ICCCCEE); Jan 16–18; Sudan: IEEE.
   Google Scholar
• Bhalerao UM, Valiveti AK, Acharya J, Halve AK, Kaushik MP. 2015. Controlled release studies of antimalarial 1, 3, 5-trisubstituted-2-pyrazolines from biocompatible chitosan-heparin layer-by-layer (LbL) self assembled thin films. Colloids Surf B Biointerfaces. 125:151–159.
   PubMed Web of Science ®Google Scholar
• Bilia AR, Bergonzi MC, Boulos JC, Efferth T. 2020. Nanocarriers to enhance solubility, bioavailability, and efficacy of artemisinins. World J Tradit Chin Med. 6(1):26.
   Google Scholar
• Blasco B, Leroy D, Fidock DA. 2017. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nat Med. 23(8):917–928.
   PubMed Web of Science ®Google Scholar
• Burns AL, Dans MG, Balbin JM, de Koning-Ward TF, Gilson PR, Beeson JG, Boyle MJ, Wilson DW. 2019. Targeting malaria parasite invasion of red blood cells as an antimalarial strategy. FEMS Microbiol Rev. 43(3):223–238.
   PubMed Web of Science ®Google Scholar
• Cabral H, Kataoka K. 2014. Progress of drug-loaded polymeric micelles into clinical studies. J Control Release. 190:465–476.
   PubMed Web of Science ®Google Scholar
• Capela R, Moreira R, Lopes F. 2019. An overview of drug resistance in protozoal diseases. Int J Mol Sci. 20(22):5748.
   Web of Science ®Google Scholar
• Chandra S, Mayer M, Baeumner AJ. 2017. PAMAM dendrimers: a multifunctional nanomaterial for ECL biosensors. Talanta. 168:126–129.
   PubMed Web of Science ®Google Scholar
• Chang M, Zhang F, Wei T, Zuo T, Guan Y, Lin G, Shao W. 2016. Smart linkers in polymer-drug conjugates for tumor-targeted delivery. J Drug Target. 24(6):475–491.
   PubMed Web of Science ®Google Scholar
• Chauhan A, Anton B, Singh MK. 2020. Dendrimers for drug solubilization, dissolution and bioavailability. Pharmaceutical applications of dendrimers. USA: Elsevier; p. 59–92.
   Google Scholar
• Chen L, Li J, Fan Y, Qiu J, Cao L, Laurent R, Mignani S, Caminade A-M, Majoral J-P, Shi X. 2020. Revisiting cationic phosphorus dendrimers as a nonviral vector for optimized gene delivery towards cancer therapy applications. Biomacromolecules. 21(6):2502–2511.
   PubMed Web of Science ®Google Scholar
• Chinappi M, Via A, Marcatili P, Tramontano A. 2010. On the mechanism of chloroquine resistance in Plasmodium falciparum. PLOS One. 5(11):e14064.
   PubMed Web of Science ®Google Scholar
• Churcher TS, Trape J-F, Cohuet A. 2015. Human-to-mosquito transmission efficiency increases as malaria is controlled. Nat Commun. 6(1):1–8.
   Google Scholar
• Coma-Cros EM, Lancelot A, San Anselmo M, Borgheti-Cardoso LN, Valle-Delgado JJ, Serrano JL, Fernàndez-Busquets X, Sierra T. 2019. Micelle carriers based on dendritic macromolecules containing bis-MPA and glycine for antimalarial drug delivery. Biomater Sci. 7(4):1661–1674.
   PubMed Web of Science ®Google Scholar
• Conrad MD, Rosenthal PJ. 2019. Antimalarial drug resistance in Africa: the calm before the storm? Lancet Infect Dis. 19(10):e338–e351.
   PubMed Web of Science ®Google Scholar
• Coppée R, Sabbagh A, Clain J. 2020. Structural and evolutionary analyses of the Plasmodium falciparum chloroquine resistance transporter. Sci Rep. 10(1):1–15.
   PubMed Web of Science ®Google Scholar
• Coronado LM, Nadovich CT, Spadafora C. 2014. Malarial hemozoin: from target to tool. Biochim Biophys Acta Gen Subj. 1840(6):2032–2041.
   PubMed Web of Science ®Google Scholar
• Cowman AF, Healer J, Marapana D, Marsh K. 2016. Malaria: biology and disease. Cell. 167(3):610–624.
   PubMed Web of Science ®Google Scholar
• Crawley J, Chu C, Mtove G, Nosten F. 2010. Malaria in children. Lancet. 375(9724):1468–1481.
   PubMed Web of Science ®Google Scholar
• Cui L, Mharakurwa S, Ndiaye D, Rathod PK, Rosenthal PJ. 2015. Antimalarial drug resistance: literature review and activities and findings of the ICEMR network. Am J Trop Med Hyg. 93(3 Suppl):57–68.
   PubMed Web of Science ®Google Scholar
• Dandekar PP, Jain R, Patil S, Dhumal R, Tiwari D, Sharma S, Vanage G, Patravale V. 2010. Curcumin-loaded hydrogel nanoparticles: application in anti-malarial therapy and toxicological evaluation. J Pharm Sci. 99(12):4992–5010.
   PubMed Web of Science ®Google Scholar
• Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2016. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 44(1):381–391.
   PubMed Web of Science ®Google Scholar
• Dawre S, Pathak S, Sharma S, Devarajan PV. 2018. Enhanced antimalalarial activity of a prolonged release in situ gel of arteether-lumefantrine in a murine model. Eur J Pharm Biopharm. 123:95–107.
   PubMed Web of Science ®Google Scholar
• Derbie A, Mekonnen D, Adugna M, Yeshitela B, Woldeamanuel Y, Abebe T. 2020. Therapeutic efficacy of Artemether-Lumefantrine (Coartem®) for the treatment of uncomplicated falciparum malaria in Africa: a systematic review. J Parasitol Res. 2020:1– 14.
   Web of Science ®Google Scholar
• Di Gennaro F, Marotta C, Pizzol D, Chhaganlal K, Monno L, Putoto G, Saracino A, Casuccio A, Mazzucco W. 2018. Prevalence and predictors of malaria in human immunodeficiency virus infected patients in beira, mozambique. IJERPH. 15(9):2032.
   Google Scholar
• Diallo I, Ouédraogo S, Zongo R, Zongo A, Niamba P, Guissou I. 2017. Adverse effects of antimalarial drugs spontaneously reported to pharmacovigilance national center in Burkina Faso: descriptive study and factors associated. Mali Medical. 32(4):21–29.
   PubMedGoogle Scholar
• Dragojevic S, Ryu JS, Raucher D. 2015. Polymer-based prodrugs: improving tumor targeting and the solubility of small molecule drugs in cancer therapy. Molecules. 20(12):21750–21769.
   PubMed Web of Science ®Google Scholar
• Duan S, Wang R, Wang R, Tang J, Xiao X, Li N, Guo W, Yang Q, Ren G, Zhang S. 2020. In vivo antimalarial activity and pharmacokinetics of artelinic acid-choline derivative liposomes in rodents. Parasitol. 147(1):58–64.
   PubMed Web of Science ®Google Scholar
• Duro-Castano A, Talelli M, Rodríguez-Escalona G, Vicent M. 2019. Smart polymeric nanocarriers for drug delivery. Smart polymers and their applications. Amsterdam: Elsevier; p. 439–479.
   Google Scholar
• Eastman RT, Fidock DA. 2009. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol. 7(12):864–874.
   PubMed Web of Science ®Google Scholar
• Ekladious I, Colson YL, Grinstaff MW. 2019. Polymer-drug conjugate therapeutics: advances, insights and prospects. Nat Rev Drug Discov. 18(4):273–294.
   PubMed Web of Science ®Google Scholar
• Elmi T, Ardestani MS, Hajialiani F, Motevalian M, Mohamadi M, Sadeghi S, Zamani Z, Tabatabaie F. 2020. Novel chloroquine loaded curcumin based anionic linear globular dendrimer G2: a metabolomics study on Plasmodium falciparum in vitro using 1 H NMR spectroscopy. Parasitol. 147:1–13.
   Web of Science ®Google Scholar
• Fattahi N, Ramazani A, Hamidi M, Parsa M, Rostamizadeh K, Rashidzadeh H. 2021. Enhancement of the brain delivery of methotrexate with administration of mid-chain ester prodrugs: in vitro and in vivo studies. Int J Pharm. 600:120479.
   PubMedGoogle Scholar
• Ferreira Soares DC, Oda CMR, Monteiro LOF, de Barros ALB, Tebaldi ML. 2019. Responsive polymer conjugates for drug delivery applications: recent advances in bioconjugation methodologies. J Drug Target. 27(4):355–366.
   PubMed Web of Science ®Google Scholar
• Fish D, Espir M. 1988. Convulsions associated with prophylactic antimalarial drugs: implications for people with epilepsy. BMJ. 297(6647):526–527.
   PubMedGoogle Scholar
• Fortuin L, Leshabane M, Pfukwa R, Coertzen D, Birkholtz L-M, Klumperman B. 2020. Facile route to targeted, biodegradable polymeric prodrugs for the delivery of combination therapy for malaria. ACS Biomater Sci Eng. 6(11):6217–6227.
   PubMed Web of Science ®Google Scholar
• Fotoran WL, Müntefering T, Kleiber N, Miranda BN, Liebau E, Irvine DJ, Wunderlich G. 2019. A multilamellar nanoliposome stabilized by interlayer hydrogen bonds increases antimalarial drug efficacy. Nanomedicine. 22:102099.
   PubMed Web of Science ®Google Scholar
• Frédérich M, Dogné J-M, Angenot L, Mol P. 2002. New trends in anti-malarial agents. Curr Med Chem. 9(15):1435–1456.
   PubMed Web of Science ®Google Scholar
• Fuge TG, Ayanto SY, Gurmamo FL. 2015. Assessment of knowledge, attitude and practice about malaria and ITNs utilization among pregnant women in Shashogo District, Southern Ethiopia. Malar J. 14(1):235.
   PubMedGoogle Scholar
• Ge P, Niu B, Wu Y, Xu W, Li M, Sun H, Zhou H, Zhang X, Xie J. 2020. Enhanced cancer therapy of celastrol in vitro and in vivo by smart dendrimers delivery with specificity and biosafety. Chem Eng J. 383:123228.
   Web of Science ®Google Scholar
• Gething PW, Casey DC, Weiss DJ, Bisanzio D, Bhatt S, Cameron E, Battle KE, Dalrymple U, Rozier J, Rao PC, et al. 2016. Mapping Plasmodium falciparum mortality in Africa between 1990 and 2015. N Engl J Med. 375(25):2435–2445.
   PubMed Web of Science ®Google Scholar
• Grabias B, Kumar S. 2016. Adverse neuropsychiatric effects of antimalarial drugs. Expert Opin Drug Saf. 15(7):903–910.
   PubMed Web of Science ®Google Scholar
• Hadjichristidis N, Pispas S, Floudas G. 2003. Block copolymers: synthetic strategies, physical properties, and applications. Toronto, Canada: John Wiley & Sons; 2003.
   Google Scholar
• Hao D-L, Xie R, De G-J, Yi H, Zang C, Yang M-Y, Liu L, Ma H, Cai W-Y, Zhao Q-H, et al. 2020. pH-Responsive artesunate polymer prodrugs with enhanced ablation effect on rodent xenograft colon cancer. Int J Nanomedicine. 15:1771–1786.
   PubMed Web of Science ®Google Scholar
• Heinberg A, Kirkman L. 2015. The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations. Ann N Y Acad Sci. 1342(1):10–18.
   PubMedGoogle Scholar
• Hu Q, Wang Y, Xu L, Chen D, Cheng L. 2020. Transferrin conjugated pH- and redox-responsive poly(amidoamine) dendrimer conjugate as an efficient drug delivery carrier for cancer therapy. Int J Nanomedicine. 15:2751–2764.
   PubMed Web of Science ®Google Scholar
• Ismail M, Du Y, Ling L, Li X. 2019. Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria. Int J Pharm. 562:162–171.
   PubMedGoogle Scholar
• Itsara LS, Zhou Y, Do J, Grieser AM, Vaughan AM, Ghosh AK. 2018. The development of whole sporozoite vaccines for Plasmodium falciparum malaria. Front Immunol. 9:2748.
   PubMed Web of Science ®Google Scholar
• Jaeger A, Sauder P, Kopferschmitt J, Flesch F. 1987. Clinical features and management of poisoning due to antimalarial drugs. Med Toxicol Adverse Drug Exp. 2(4):242–273.
   PubMedGoogle Scholar
• Jaeger VK, Tschudi N, Rüegg R, Hatz C, Bühler S. 2015. The elderly, the young and the pregnant traveler – a retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever vaccination. Travel Med Infect Dis. 13(6):475–484.
   PubMedGoogle Scholar
• Jain M, Nevin RL, Ahmed I. 2016. Mefloquine-associated dizziness, diplopia, and central serous chorioretinopathy: a case report. J Med Case Rep. 10(1):305.
   PubMedGoogle Scholar
• Jawahar N, Baruah UK, Singh V. 2019. Co-delivery of chloroquine phosphate and azithromycin nanoparticles to overcome drug resistance in malaria through intracellular targeting. J Pharm Sci Res. 11(1):33–40.
   Google Scholar
• Kayode AT, Akano K, Ajogbasile FV, Uwanibe JN, Oluniyi PE, Bankole BE, Eromon PJ, Sowunmi A, Folarin OA, Volkman SK, et al. 2021. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and multidrug-resistant gene 1 (Pfmdr-1) in Nigerian children 10 years post-adoption of artemisinin-based combination treatments. Int J Parasitol. 51(4):301–310.
   PubMed Web of Science ®Google Scholar
• Kheir A. 2011. Factors influencing evolution to antimalarial drug resistance in Plasmodium falciparum in Sudan and The Gambia. Sweden: Acta Universitatis Upsaliensis.
   Google Scholar
• Klumperman L, Reader PW, Rautenbach M. 2019. Conjugate for treating malaria. Google Patents.
   Google Scholar
• Korhonen C, Peterson K, Bruder C, Jung P. 2007. Self-reported adverse events associated with antimalarial chemoprophylaxis in peace corps volunteers. Am J Prev Med. 33(3):194–199.
   PubMed Web of Science ®Google Scholar
• Kuhn Y, Rohrbach P, Lanzer M. 2007. Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin . Cell Microbiol. 9(4):1004–1013.
   PubMed Web of Science ®Google Scholar
• Lee Y, Thompson D. 2017. Stimuli‐responsive liposomes for drug delivery. WIREs Nanomed Nanobiotechnol. 9(5):e1450.
   Google Scholar
• Luzzi GA, Peto TE. 1993. Adverse effects of antimalarials. An update. Drug Saf. 8(4):295–311.
   PubMed Web of Science ®Google Scholar
• Mallick S, Choi JS. 2014. Liposomes: versatile and biocompatible nanovesicles for efficient biomolecules delivery. J Nanosci Nanotechnol. 14(1):755–765.
   PubMed Web of Science ®Google Scholar
• Manjili HK, Malvandi H, Mousavi MS, Attari E, Danafar H. 2018. In vitro and in vivo delivery of artemisinin loaded PCL-PEG-PCL micelles and its pharmacokinetic study. Artif Cells Nanomed Biotechnol. 46(5):926–936.
   PubMed Web of Science ®Google Scholar
• Manjili HRK, Malvandi H, Mosavi M-S, Danafar H. 2016. Preparation and physicochemical characterization of biodegradable mPEG-PCL core-shell micelles for delivery of artemisinin. Pharm Sci. 22(4):234–243.
   Google Scholar
• Mansilla E, Marin GH, Nunez L, Drago H, Sturla F, Mertz C, Rivera L, Ichim T, Riordan N, Raimondi C. 2010. The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitro. Cancer Biother Radiopharm. 25(1):97–103.
   PubMed Web of Science ®Google Scholar
• Martí Coma-Cros E. 2019. Investigation of branched and linear polymers as oral delivery systems of antimalarial drugs. Barcelona, Spain: Universitat de Barcelona.
   Google Scholar
• Martí Coma-Cros E, Biosca A, Marques J, Carol L, Urbán P, Berenguer D, Riera M, Delves M, Sinden R, Valle-Delgado J, et al. 2018. Polyamidoamine nanoparticles for the oral administration of antimalarial drugs. Pharmaceutics. 10(4):225.
   Web of Science ®Google Scholar
• Mehta H, Nagtilak S, Rai S, Joglekar Y, Thombre H, Mirani H. 2020. Detection of malaria parasite using deep learning. EasyChair. 20:2516–2314.
   Google Scholar
• Meibalan E, Marti M. 2017. Biology of malaria transmission. Cold Spring Harb Perspect Med. 7(3):a025452.
   PubMed Web of Science ®Google Scholar
• Mhlwatika Z, Aderibigbe BA. 2018. Polymeric nanocarriers for the delivery of antimalarials. Molecules. 23(10):2527.
   PubMed Web of Science ®Google Scholar
• Miatmoko A, Salim H, Zahro SM, Annuryanti F, Sari R, Hendradi E. 2019. Dual loading of primaquine and chloroquine into liposome. Eur Pharm J. 66(2):18–25.
   Google Scholar
• Michels LR, Maciel TR, Nakama KA, Teixeira FEG, de Carvalho FB, Gundel A, de Araujo BV, Haas SE. 2019. Effects of surface characteristics of polymeric nanocapsules on the pharmacokinetics and efficacy of antimalarial quinine. Int J Nanomedicine. 14:10165–10178.
   PubMed Web of Science ®Google Scholar
• Mita T, Tanabe K. 2012. Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance. Jpn J Infect Dis. 65(6):465–475.
   PubMed Web of Science ®Google Scholar
• Moles E, Kavallaris M, Fernàndez-Busquets X. 2019. Modelling the distribution of diprotic basic drugs in liposomal systems: perspectives on malaria nanotherapy. Front Pharmacol. 10:1064–1080.
   PubMed Web of Science ®Google Scholar
• Movellan J, Urbán P, Moles E, Jesús M, Sierra T, Serrano JL, Fernàndez-Busquets X. 2014. Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs. Biomaterials. 35(27):7940–7950.
   PubMed Web of Science ®Google Scholar
• Mukaya H, Van Zyl R, Van Vuuren N, Mbianda X. 2017. Synthesis and characterization of water-soluble polyaspartamides containing platinum (II) complex and bisphosphonate as potential antimalarial drug. Polym Bull. 74(8):3161–3178.
   Web of Science ®Google Scholar
• Müller M, Agarwal N, Kim J. 2016. A cytochrome P450 3A4 biosensor based on generation 4.0 PAMAM dendrimers for the detection of caffeine. Biosens. 6(3):44.
   Google Scholar
• Nayyar GM, Breman JG, Newton PN, Herrington J. 2012. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 12(6):488–496.
   PubMed Web of Science ®Google Scholar
• Njunda AL, Njumkeng C, Nsagha SD, Assob JCN, Kwenti TE. 2016. The prevalence of malaria in people living with HIV in Yaounde, Cameroon. BMC Public Health. 16(1):964.
   PubMedGoogle Scholar
• Nosrati H, Salehiabar M, Bagheri Z, Rashidzadeh H, Davaran S, Danafar H. 2018. Preparation, characterization, and evaluation of amino acid modified magnetic nanoparticles: drug delivery and MRI contrast agent applications. Pharm Dev Technol. 23(10):1156–1167.
   PubMed Web of Science ®Google Scholar
• Nosten F, Brasseur P. 2002. Combination therapy for malaria: the way forward?. Drugs. 62(9):1315–1329.
   PubMed Web of Science ®Google Scholar
• Olliaro P, Goldberg D. 1995. The Plasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol Today. 11(8):294–297.
   PubMedGoogle Scholar
• Organization WH. 2015. WHO Fact Sheet: World Malaria Report, 9 December 2015. World Health. 243:10–13.
   Google Scholar
• Organization WH. 2018. World Malaria Report 2018. Geneva, Switzerland: World Health Organization.
   Google Scholar
• Owen SC, Chan DP, Shoichet MS. 2012. Polymeric micelle stability. Nano Today. 7(1):53–65.
   Web of Science ®Google Scholar
• Owonubi S, Aderibigbe B, Mukwevho E, Sadiku ER, Ray SS. 2018. Characterization and in vitro release kinetics of antimalarials from whey protein-based hydrogel biocomposites. Int J Ind Chem. 9(1):39–52.
   Web of Science ®Google Scholar
• Oyeyemi O, Morenkeji O, Afolayan F, Dauda K, Busari Z, Meena J, Panda A. 2018. Curcumin-artesunate based polymeric nanoparticle; antiplasmodial and toxicological evaluation in murine model. Front Pharmacol. 9:562–569.
   PubMed Web of Science ®Google Scholar
• Palafox JI, Linares LG, Reyes-Cruz V, Flores MB, Ledezma JR, Alvarez CG, Flores AA, Garcia JB. 2020. In vitro redox activity of haemozoin and β-haemozoin interacting with the following antimalarials: artemether, lumefantrine and quinine. Eur Rev Med Pharmacol Sci. 24:7063–7076.
   PubMed Web of Science ®Google Scholar
• Paleos CM, Tsiourvas D, Sideratou Z, Tziveleka L-A. 2010. Drug delivery using multifunctional dendrimers and hyperbranched polymers. Expert Opin Drug Deliv. 7(12):1387–1398.
   PubMed Web of Science ®Google Scholar
• Panda BB, Hazra RK. 2020. Nanotechnology and its role in malaria treatment. Green Nanoparticles. New York City: Springer. 347–358.
   Google Scholar
• Pang X, Jiang Y, Xiao Q, Leung AW, Hua H, Xu C. 2016. pH-responsive polymer-drug conjugates: design and progress. J Control Release. 222:116–129.
   PubMed Web of Science ®Google Scholar
• Pang X, Yang X, Zhai G. 2014. Polymer-drug conjugates: recent progress on administration routes. Expert Opin Drug Deliv. 11(7):1075–1086.
   PubMed Web of Science ®Google Scholar
• Patel V, Rajani C, Paul D, Borisa P, Rajpoot K, Youngren-Ortiz SR, Tekade RK. 2020. Dendrimers as novel drug-delivery system and its applications. Drug Delivery Systems. Amsterdam, Netherland: Elsevier; p. 333–392.
   Google Scholar
• Phillips MA, Burrows JN, Manyando C, van Huijsduijnen RH, Van Voorhis WC, Wells TNC. 2017. Malaria. Nat Rev Dis Primers. 3:17050.
   PubMed Web of Science ®Google Scholar
• Puttappa N, Kumar RS, Kuppusamy G, Radhakrishnan A. 2019. Nano-facilitated drug delivery strategies in the treatment of plasmodium infection. Acta Trop. 195(2019):103–114.
   PubMedGoogle Scholar
• Rai DB, Gupta N, Pooja D, Kulhari H. 2020. Dendrimers for diagnostic applications. Pharmaceutical applications of dendrimers. Amsterdam, Netherland: Elsevier; p. 291–324.
   Google Scholar
• Rai DB, Pooja D, Kulhari H. 2020. Dendrimers in gene delivery. Pharmaceutical applications of dendrimers. Amsterdam, Netherland: Elsevier; p. 211–231.
   Google Scholar
• Rajani C, Borisa P, Karanwad T, Borade Y, Patel V, Rajpoot K, Tekade RK. 2020. Cancer-targeted chemotherapy: emerging role of the folate anchored dendrimer as drug delivery nanocarrier. Pharmaceutical applications of dendrimers. Amsterdam, Netherland: Elsevier; p. 151–198.
   Google Scholar
• Ramazani A, Keramati M, Malvandi H, Danafar H, Kheiri Manjili H. 2018. Preparation and in vivo evaluation of anti-plasmodial properties of artemisinin-loaded PCL-PEG-PCL nanoparticles. Pharm Dev Technol. 23(9):911–920.
   PubMed Web of Science ®Google Scholar
• Rashidzadeh H, Danafar H, Rahimi H, Mozafari F, Salehiabar M, Rahmati MA, Rahamooz-Haghighi S, Mousazadeh N, Mohammadi A, Ertas YN. 2021. Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives. Nanomedicine. 16(6).
   PubMed Web of Science ®Google Scholar
• Rashidzadeh H, Rezaei SJT, Zamani S, Sarijloo E, Ramazani A. 2021. pH-sensitive curcumin conjugated micelles for tumor triggered drug delivery. J Biomater Sci Polym Ed. 32(3):320–336.
   PubMed Web of Science ®Google Scholar
• Rashidzadeh H, Salimi M, Sadighian S, Rostamizadeh K, Ramazani A. 2019. In vivo antiplasmodial activity of curcumin-loaded nanostructured lipid carriers. Curr Drug Deliv. 16(10):923–930.
   PubMed Web of Science ®Google Scholar
• Rezaei SJT, Sarijloo E, Rashidzadeh H, Zamani S, Ramazani A, Hesami A, Mohammadi E. 2020. pH-triggered prodrug micelles for cisplatin delivery: preparation and in vitro/vivo evaluation. React Funct Polym. 146:104399.
   Web of Science ®Google Scholar
• Rideau E, Dimova R, Schwille P, Wurm FR, Landfester K. 2018. Liposomes and polymersomes: a comparative review towards cell mimicking. Chem Soc Rev. 47(23):8572–8610.
   PubMed Web of Science ®Google Scholar
• Rifaie-Graham O, Pollard J, Raccio S, Balog S, Rusch S, Hernández-Castañeda MA, Mantel P-Y, Beck H-P, Bruns N. 2019. Hemozoin-catalyzed precipitation polymerization as an assay for malaria diagnosis. Nat Commun. 10(1):1–8.
   PubMedGoogle Scholar
• Rodriguez-Caruncho C, Marsol IB. 2014. Antimalarials in dermatology: mechanism of action, indications, and side effects. Actas Dermosifiliogr. 105(3):243–252.
   PubMedGoogle Scholar
• Rosenthal MR, Ng CL. 2020. P. falciparum artemisinin resistance: the effect of heme, protein damage, and parasite cell stress response. ACS Infect Dis. 6(7):1599–1614.
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. 2010. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 69(1):20–28.
   PubMed Web of Science ®Google Scholar
• Sadjadi S. 2016. Dendrimers as nanoreactors. Organic nanoreactors. Netherlands: Elsevier; p. 159–201.
   Google Scholar
• Sahoo RK, Gothwal A, Rani S, Nakhate KT, Gupta U. 2020. PEGylated dendrimer mediated delivery of bortezomib: drug conjugation versus encapsulation. Int J Pharm. 584:119389.
   PubMedGoogle Scholar
• Saifi MA, Beg T, Harrath AH, Altayalan FSH, Al QS. 2013. Antimalarial drugs: mode of action and status of resistance. Afr J Pharm Pharmacol. 7(5):148–156.
   Google Scholar
• Salako L. 1984. Toxicity and side-effects of antimalarials in Africa: a critical review. Bull World Health Organ. 62(Suppl):63.
   PubMedGoogle Scholar
• Saliba KJ, Folb PI, Smith PJ. 1998. Role for the Plasmodium falciparum digestive vacuole in chloroquine resistance. Biochem Pharmacol. 56(3):313–320.
   PubMed Web of Science ®Google Scholar
• Seifu MF, Nath LK. 2019. Polymer-drug conjugates: novel carriers for cancer chemotherapy. Polym Plast Technol Eng. 58(2):158–171.
   Web of Science ®Google Scholar
• Shakeel K, Raisuddin S, Ali S, Imam SS, Rahman MA, Jain GK, Ahmad FJ. 2019. Development and in vitro/in vivo evaluation of artemether and lumefantrine co-loaded nanoliposomes for parenteral delivery. J Liposome Res. 29(1):35–43.
   PubMed Web of Science ®Google Scholar
• Shende P, Sahu P. 2020. Enzyme bioconjugated PAMAM dendrimers for estimation of glucose in saliva. Int J Polym Mater. 70:1–7.
   Web of Science ®Google Scholar
• Shibeshi MA, Kifle ZD, Atnafie SA. 2020. Antimalarial drug resistance and novel targets for antimalarial drug discovery. IDR. 13:4047–4060.
   Google Scholar
• Sidhu ABS, Verdier-Pinard D, Fidock DA. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by PFCRT mutations. Science. 298(5591):210–213.
   PubMed Web of Science ®Google Scholar
• Simwela NV, Hughes KR, Rennie MT, Barrett MP, Waters AP. 2021. Mammalian deubiquitinating enzyme inhibitors display in vitro and in vivo activity against malaria parasites and potentiate artemisinin action. ACS Infect Dis. 7(2):333–346.
   PubMed Web of Science ®Google Scholar
• Singh AV, Raichur AM, Dyawanapelly S. 2015. Conjugates, polymer–drug: targeted cancer treatment. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, 11 Volume Set. London, UK: CRC Press; p. 2089–2112.
   Google Scholar
• Srivastava A, Yadav T, Sharma S, Nayak A, Kumari AA, Mishra N. 2015. Polymers in drug delivery. J Biosci Med. 4(1):69–84.
   Google Scholar
• Stone WJR, Eldering M, van Gemert G-J, Lanke KHW, Grignard L, van de Vegte-Bolmer MG, Siebelink-Stoter R, Graumans W, Roeffen WFG, Drakeley CJ, et al. 2013. The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays. Sci Rep. 3:3418.
   PubMed Web of Science ®Google Scholar
• Subramanian G, Sadeer A, Mukherjee K, Kojima T, Tripathi P, Naidu R, Tay SW, Pang JH, Pullarkat SA, Chandramohanadas R. 2019. Evaluation of ferrocenyl phosphines as potent antimalarials targeting the digestive vacuole function of Plasmodium falciparum. Dalton Trans. 48(3):1108–1117.
   PubMed Web of Science ®Google Scholar
• Svenson S. 2015. The dendrimer paradox–high medical expectations but poor clinical translation. Chem Soc Rev. 44(12):4131–4144.
   PubMed Web of Science ®Google Scholar
• Talelli M, Barz M, Rijcken CJ, Kiessling F, Hennink WE, Lammers T. 2015. Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation. Nano Today. 10(1):93–117.
   PubMed Web of Science ®Google Scholar
• Tang Y-Q, Ye Q, Huang H, Zheng W-Y. 2020. An overview of available antimalarials: discovery, mode of action and drug resistance. CMM. 20(8):583–592.
   PubMed Web of Science ®Google Scholar
• Tilley L, Dixon MW, Kirk K. 2011. The Plasmodium falciparum-infected red blood cell. Int J Biochem Cell Bio. 43(6):839–842.
   PubMed Web of Science ®Google Scholar
• Tomalia DA. 2005. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog Polym Sci. 30(3–4):294–324.
   Web of Science ®Google Scholar
• Tripathy S, Das S, Chakraborty SP, Sahu SK, Pramanik P, Roy S. 2012. Synthesis, characterization of chitosan-tripolyphosphate conjugated chloroquine nanoparticle and its in vivo anti-malarial efficacy against rodent parasite: a dose and duration dependent approach . Int J Pharm. 434(1–2):292–305.
   PubMedGoogle Scholar
• Tunki L, Kulhari H, Sistla R, Pooja D. 2020. Dendrimer-based targeted drug delivery. Pharmaceutical applications of dendrimers. Amsterdam, Netherlands: Elsevier; p. 107–129.
   Google Scholar
• Urbán P, Ranucci E, Fernàndez-Busquets X. 2015. Polyamidoamine nanoparticles as nanocarriers for the drug delivery to malaria parasite stages in the mosquito vector. Nanomed. 10(22):3401–3414.
   PubMedGoogle Scholar
• Vale N, Moreira R, Gomes P. 2009. Primaquine revisited six decades after its discovery. Eur J Med Chem. 44(3):937–953.
   PubMed Web of Science ®Google Scholar
• Vieira Gonzaga R, da Silva Santos S, Da Silva JV, Campos Prieto D, Feliciano Savino D, Giarolla J, Igne Ferreira E. 2018. Targeting groups employed in selective dendrons and dendrimers. Pharmaceutics. 10(4):219.
   Web of Science ®Google Scholar
• Wassmer SC, Taylor TE, Rathod PK, Mishra SK, Mohanty S, Arevalo-Herrera M, Duraisingh MT, Smith JD. 2015. Investigating the pathogenesis of severe malaria: a multidisciplinary and cross-geographical approach. Am J Trop Med Hyg. 93(3 Suppl):42–56.
   PubMed Web of Science ®Google Scholar
• Whegang SY, Tahar R, Foumane VN, Soula G, Gwét H, Thalabard J-C, Basco LK. 2010. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon. Malar J. 9(1):56.
   PubMedGoogle Scholar
• White N. 1999. Antimalarial drug resistance and mortality in falciparum malaria. Trop Med Int Health. 4(7):469–470.
   PubMed Web of Science ®Google Scholar
• Wunderlich J, Rohrbach P, Dalton JP. 2012. The malaria digestive vacuole. Front Biosci. 4:1424–1448.
   Google Scholar
• Xie SC, Ralph SA, Tilley L. 2020. K13, the cytostome, and artemisinin resistance. Trends Parasitol. 4:1424–1448.
   Google Scholar
• Yaméogo JBG, Mazet R, Wouessidjewe D, Choisnard L, Godin-Ribuot D, Putaux J-L, Semdé R, Gèze A. 2020. Pharmacokinetic study of intravenously administered artemisinin-loaded surface-decorated amphiphilic γ-cyclodextrin nanoparticles. Mater Sci Eng C. 106:110281.
   PubMed Web of Science ®Google Scholar
• Zhao W, Liu F, Chen Y, Bai J, Gao W. 2015. Synthesis of well-defined protein–polymer conjugates for biomedicine. Polymer. 66:A1–A10.
   Web of Science ®Google Scholar